Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRIS: Ferric Carboxymaltose vs Iron Sucrose for Postoperative Anemia in Gastric Cancer
NCT07772453Phase 4Not yet recruiting
- Start
- Aug 2026
- Primary completion
- Nov 2027
01
Overview
A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA). Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07772453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772453.